company background image
SFZN

Siegfried Holding SWX:SFZN Stock Report

Last Price

CHF707.00

Market Cap

CHF3.0b

7D

1.4%

1Y

-23.2%

Updated

17 Aug, 2022

Data

Company Financials +
SFZN fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance4/6
Financial Health4/6
Dividends0/6

SFZN Stock Overview

Siegfried Holding AG engages in the life sciences business worldwide.

Siegfried Holding AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Siegfried Holding
Historical stock prices
Current Share PriceCHF707.00
52 Week HighCHF923.00
52 Week LowCHF566.00
Beta0.80
1 Month Change7.61%
3 Month Change14.31%
1 Year Change-23.19%
3 Year Change84.60%
5 Year Change150.49%
Change since IPO830.26%

Recent News & Updates

Jun 24
Should You Be Adding Siegfried Holding (VTX:SFZN) To Your Watchlist Today?

Should You Be Adding Siegfried Holding (VTX:SFZN) To Your Watchlist Today?

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Shareholder Returns

SFZNCH Life SciencesCH Market
7D1.4%-0.6%-0.6%
1Y-23.2%-29.5%-13.6%

Return vs Industry: SFZN exceeded the Swiss Life Sciences industry which returned -28.7% over the past year.

Return vs Market: SFZN underperformed the Swiss Market which returned -12.9% over the past year.

Price Volatility

Is SFZN's price volatile compared to industry and market?
SFZN volatility
SFZN Average Weekly Movement5.2%
Life Sciences Industry Average Movement6.5%
Market Average Movement4.5%
10% most volatile stocks in CH Market7.8%
10% least volatile stocks in CH Market2.4%

Stable Share Price: SFZN is not significantly more volatile than the rest of Swiss stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: SFZN's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
18733,488Wolfgang Wienandhttps://www.siegfried.ch

Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production.

Siegfried Holding AG Fundamentals Summary

How do Siegfried Holding's earnings and revenue compare to its market cap?
SFZN fundamental statistics
Market CapCHF3.00b
Earnings (TTM)CHF95.60m
Revenue (TTM)CHF1.10b

31.4x

P/E Ratio

2.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SFZN income statement (TTM)
RevenueCHF1.10b
Cost of RevenueCHF862.85m
Gross ProfitCHF239.57m
Other ExpensesCHF143.97m
EarningsCHF95.60m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

Aug 18, 2022

Earnings per share (EPS)22.51
Gross Margin21.73%
Net Profit Margin8.67%
Debt/Equity Ratio69.7%

How did SFZN perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

14%

Payout Ratio